<?xml version="1.0" encoding="UTF-8"?>
<p>Human granulocytic anaplasmosis (HGA) is another emerging tick-borne zoonosis, which was first reported in the United States in 1990 and in Europe in 1997 [
 <xref ref-type="bibr" rid="B45">45</xref>]. As the causative rickettsia was reclassified from the genus 
 <italic>Ehrlichia</italic> to 
 <italic>Anaplasma phagocytophilum</italic>, the disease name was changed from human granulocytic ehrlichiosis to HGA in 2001 [
 <xref ref-type="bibr" rid="B22">22</xref>,
 <xref ref-type="bibr" rid="B45">45</xref>]. The pathogen causes the disease by infecting human neutrophils [
 <xref ref-type="bibr" rid="B21">21</xref>,
 <xref ref-type="bibr" rid="B46">46</xref>]. The symptoms of HGA are similar to HME, and deaths from HGA are approximately 0.6% of those infected and typically involve those immunocompromised individuals, usually 10 or more days after disease onset [
 <xref ref-type="bibr" rid="B43">43</xref>,
 <xref ref-type="bibr" rid="B46">46</xref>].
</p>
